Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Fintel reports that on October 17, 2024, Bernstein initiated coverage of Pfizer (NYSE:PFE) with a Market Perform ...

Guggenheim has earned $172 million from advising Pfizer on nearly $400 billion in acquisitions since 2011. Pfizer’s stock has ...

(Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing it of ...

The stock's rise snapped a three-day losing streak.

Real-time index price for S&P 500 Energy [Sector] (SREN), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...

U.S. stocks were pulling back from record territory in the final hour of trade Thursday as investors looked forward to big ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock, giving a Hold rating on October 7. David ...

While shares have posted break-even returns so far in 2024, Pfizer stock has cratered by more than 30% over the ...

Real-time index price for S&P 100 Index (OEX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...